Lead sponsor
Joslin Diabetes Center
3 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
3
Trials led
1
Active
154
Total enrollment
1
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 4
2
Not applicable
1
Trials by status
Recruiting
1
Completed
2
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
The Effect of Exenatide Compared to Lantus Insulin on Vascular Function in Type 2 DiabetesHbA1c ≥7%Ph 4Completed72
Nutrition+: Effect of a High-Protein Diabetes Formula on Body Composition in Type 2 Diabetes Patients Treated With Incretin MimeticsBMI ≥25not applicableRecruiting60